BiomaterialsBioprintingMedicalMoney & Funding

Dimension Inx raises more than $3M in seed financing

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Dimension Inx raised $3.175 million to close its series seed financing round. The next-generation biofabrication company was notably supported by KdT Ventures, with Better Ventures and Revolution’s Rise also participating in the seed funding round.

Dimension takes a materials-centric approach to its work. Founded in 2017, the company produces medical-grade materials like Hyperelastic Bone and 3D-Graphene. The company produces metals, alloys, ceramics, and other materials for medical applications. The company’s patented materials design and manufacturing platform creates 3D-printed implants for tissue repair and regeneration. The technology platform overcomes existing challenges in biomaterials and additive manufacturing, which enables important compositional and microstructural features that would otherwise not be commercially feasible.

The new financing will support the commercial development and FDA approval of the company’s first therapeutic implants for facial reconstruction in patients following trauma as well as those with dental malformations due to congenital defects or aging. The company expects to complete pre-clinical studies for FDA 510(k) submission next summer.

Advanced BioMatrix Dimension Inx partnership
Printed with 3D-Graphene


“We are incredibly fortunate to partner with investors who support our big vision and appreciate our pragmatic approach to the market, while also understanding the deep science involved in getting there,” said Dimension CEO Dr. Caralynn Nowinski Collens. “We’re looking forward to advancing the science and expanding our strategic  partnerships to address a much broader set of surgical applications.”

KdT Ventures is an early-stage science venture investing that helps founders and their companies re-imagine the world at a molecular level. KdT Ventures uses its expertise across multiple disciplines and industries to invest in and support meaningful teams applying computation to chemical and biological systems, including companies like PathAI, Dyno, Solugen, Checkerspot and 54Gene. The seed financing that it has provided to Dimension allows the company to leverage KdT’s connections and knowledge. 

“Dimension Inx is the materials specialist of 3D bioprinting,” said Phil Grayeski of KdT Ventures. “Their approach to commercialization and regulatory approval is elegant and pragmatic, with each new product demonstrating the capabilities of their materials and informing the development and validation of their platform across broader and more complex applications in regenerative medicine. We believe  the bioprinting world will be built upon the scaffolds Dimension Inx is creating, and we’re thrilled to be  supporting this company.”

Research 2021
Ceramic AM Market Opportunities and Trends

This market study from 3dpbm Research provides an in-depth analysis and forecast of the ceramic additive ma...

Adam Strömbergsson

Adam is a legal researcher and writer with a background in law and literature. Born in Montreal, Canada, he has spent the last decade in Ottawa, Canada, where he has worked in legislative affairs, law, and academia. Adam specializes in his pursuits, most recently in additive manufacturing. He is particularly interested in the coming international and national regulation of additive manufacturing. His past projects include a history of his alma mater, the University of Ottawa. He has also specialized in equity law and its relationship to judicial review. Adam’s current interest in additive manufacturing pairs with his knowledge of historical developments in higher education, copyright and intellectual property protections.

Related Articles

Back to top button

We use cookies to give you the best online experience and for ads personalisation. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services



Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*